NURA Health Screening Center will Open in Ulaanbaatar, Mongolia

TOKYO, September 13, 2023 - FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) announces the upcoming opening of a new "NURA" health screening center focusing on cancer and lifestyle diseases screening in Mongolia.

The opening of the center follows the conclusion of a technology partnership contract between the Fujifilm subsidiary FUJIFILM DKH LLP, which operates three NURA centers in India, and Tavan Bogd Group, a Mongolian conglomerate. Under the partnership contract, the Tavan Bogd Group will open a NURA health screening center in Ulaanbaatar on September 17, 2023.

By expanding its health screening service business, Fujifilm aims to contribute toward the early detection of cancer and lifestyle diseases in emerging countries. The new NURA center in Mongolia will be the first center opened under a technology partnership contract.

In Mongolia, cancer and lifestyle diseases such as ischemic heart disease are leading causes of death^*1. The number of patients dying or falling critically ill as a result of these diseases can be reduced through early disease detection followed by appropriate treatment and health guidance.  However, health screening services in Mongolia are not as widely available as in Japan, which frequently makes it difficult to detect diseases in their early stages.

Fujifilm will share its expertise it has gained from operating NURA centers in India with the Tavan Bogd Group that has worked with Fujifilm in its photo imaging business since 1995. Fujifilm and the Tavan Bogd Group will work together to create an environment that supports the delivery of high-quality screening services in Mongolia and contribute to the early detection of cancer and lifestyle diseases in Mongolia. In addition, Fujifilm and the Tavan Bogd Group will work to promote the adoption of a health screening culture in Mongolia.

Fujifilm has been providing health screening services in India, with three NURA centers in the cities of Bengaluru, Gurugram and Mumbai, which were opened in 2021, 2022, and 2023 respectively. NURA utilizes Fujifilm's medical devices including CT scan and mammography system, as well as medical IT system based on AI technology that are designed to support doctors carry out screening and tests for cancer and lifestyle diseases. The convenience of completing all checks in just about 120 minutes and hearing results directly from a doctor while viewing diagnostic images has been highly acclaimed, and NURA has already been used by about 12,000 people.

Fujifilm will continue to establish new NURA health screening centers in emerging countries in Southeast Asia, the Middle East, and Africa, working where necessary in partnership with other companies where effective. Through NURA centers equipped with Fujifilm's medical devices and AI-based medical IT system that provides interpretation assistance to doctors, Fujifilm will continue to provide high-quality services to an increasing number of people, thereby contributing to advancement of global health and maintaining and promoting people's health.

• *1 Source: “Global Health Estimates: Life expectancy and leading causes of death and disability” on WHO website.

• * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.